Receive the latest updates from Matrix Medical in real time to understand product information.
On November 19, 2024, Hangzhou, a city full of innovation and vitality, once again witnessed a brilliant moment in the field of medical devices. In the "7th (2024) China Medical Device Innovation and Entrepreneurship Competition Industrial Transformation (Yangtze River Delta) Special Competition and" Talent Gathering in Changxing, Smart Winning in the Future "Innovation and Entrepreneurship Competition Hangzhou Branch Competition, Matrix Medical stood out with its innovative project of" Coronary Vascular Remodeling Catheter "and won high recognition from the judges, winning the second prize.
This competition is jointly guided by the National Medical Device Industry Technology Innovation Alliance, Zhejiang Medical Device Industry Association, and the Organization Department (Talent Office) of Huzhou Municipal Party Committee. It is the national professional competition with the largest number of participating projects, the best quality, the strongest professionalism, the highest level of expert judges, the greatest industry influence, and the most outstanding achievements in China.There are over 100 talent entrepreneurship projects in the field, covering multiple cutting-edge sub fields such as medical imaging, biomaterials, in vitro diagnostics, and smart wearables, with extremely fierce competition. After a series of rigorous screening processes including initial material review, expert evaluation, and on-site inspections, only 14 projects stood out and were shortlisted for the finals.
In this era of innovation driven development, every spark of innovation has the potential to illuminate the future of the industry. Behind the honor lies the unwavering pursuit of quality and persistent commitment to innovation by the Matrix Medical team. We deeply understand that only through continuous innovation can we stand invincible in the fierce market competition; Only by pursuing excellence can we bring better products and services to users.
